ArticleJournal of human reproductive sciences

A Multicenter Phase IV Study to Investigate the Immunogenicity of Recombinant Human Follicle-Stimulating Hormone and Its Impact on Clinical Outcomes in Females Undergoing Controlled Ovarian Stimulation.

Abha Majumdar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.